She performed her residency in internal medicine at the University of Medicine and Dentistry of Newark, NJ. Dr. Hsu continued her studies and performed her fellowship training in rheumatology at Robert Wood Johnson. Dr. Hsu is the Director of the UMDNJ Scleroderma Research Program. This research actively involves multiple clinical trials of novel treatments and antifibrotic agents for systemic sclerosis. The research aims to find better treatment options for pulmonary fibrosis, pulmonary hypertension, Raynaud's, digital ulcers, myopathy, and other complications seen with this devastating disease.